Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytopathologic Diagnosis of Non-Neoplastic Inflammatory Disorders of Lymphoid Organs.

Acta cytologica·2025
Same author

The World Health Organization Reporting System for Lymph Node, Spleen, and Thymus Cytopathology: Part 2 - Spleen and Thymus.

Acta cytologica·2025
Same author

The Unexpected Abdominal Mass in a 3-Year-Old.

Cytopathology : official journal of the British Society for Clinical Cytology·2025
Same author

The World Health Organization Reporting System for Lymph Node, Spleen, and Thymus Cytopathology: Part 1 - Lymph Node.

Acta cytologica·2025
Same author

Central Neurocytoma Diagnosis on Squash Cytology.

Journal of cytology·2024
Same author

Cytological diagnosis of lymphoepithelial carcinoma: Simple yet confusing.

Diagnostic cytopathology·2024

Related Experiment Video

Updated: May 29, 2026

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

Malignant small round cell tumors.

Arvind Rajwanshi1, Radhika Srinivas, Gautam Upasana

  • 1Department of Cytology and Gynecologic Pathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Journal of Cytology
|September 23, 2011
PubMed
Summary

Diagnosing malignant small round cell tumors is challenging due to their undifferentiated nature. A multimodal approach using fine needle aspiration cytology (FNAC) and ancillary techniques like molecular genetics aids accurate classification.

Keywords:
Fine needle aspiration cytologyancillary techniquesmalignant small round cell tumors

More Related Videos

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
08:57

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Related Experiment Videos

Last Updated: May 29, 2026

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
08:57

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Area of Science:

  • Oncology
  • Pathology
  • Genetics

Background:

  • Malignant small round cell tumors (MSRCTs) are a group of neoplasms characterized by small, undifferentiated cells.
  • Differential diagnosis is difficult due to the primitive nature of these tumors, often hindering definitive morphological identification.
  • Common examples include Ewing's sarcoma, neuroblastoma, and Wilms' tumor, among others.

Purpose of the Study:

  • To highlight the diagnostic challenges associated with malignant small round cell tumors.
  • To emphasize the utility of fine needle aspiration cytology (FNAC) in obtaining diagnostic material.
  • To review the ancillary techniques crucial for accurate classification of MSRCTs.

Main Methods:

  • Fine needle aspiration cytology (FNAC) for cell collection.
  • Immunohistochemistry and immunophenotyping by flow cytometry.
  • Molecular genetic approaches including RT-PCR and FISH.

Main Results:

  • FNAC provides viable cells suitable for various ancillary diagnostic techniques.
  • A multimodal diagnostic approach combining cytology with ancillary methods improves classification accuracy.
  • Molecular genetic characterization of chromosomal breakpoints and genes offers precise detection capabilities.

Conclusions:

  • Accurate diagnosis of MSRCTs often requires a combination of morphological assessment and advanced ancillary techniques.
  • FNAC is a valuable initial diagnostic tool for MSRCTs.
  • Molecular diagnostics play an increasingly important role in the precise classification and understanding of MSRCTs.